Company attributes
Industry
B2X
Founder
Pitchbook URL
Date Incorporated
2012
Number of Employees (Ranges)
11 – 50
Email Address
job-v04190@mail.flatchr.io
info@depixus.com
Phone Number
+33972632889
+441223628860
Full Address
3-5 3 IMPASSE REILLE PARIS 14 75014 PARIS FRANCE
Founded Date
January 1, 2012
Total Funding Amount (USD)
73,999,019
Latest Funding Round Date
December 16, 2021
Latest Funding Type
Patents Assigned (Count)
1
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
35,400,000
Depixus is a developer of a single molecule genetic and epigenetic sequencing technology intended to offer extraction of genetic and epigenetic information from single molecules of DNA and RNA. The company's technology SIMDEQ (SIngle-molecule Magnetic DEtection and Quantification) permits a full genome or genomic region to be analyzed quickly and easily on a single integrated platform, with the investigator to specify the level of sequence and epigenetic detail required, enabling users with simple sample-preparation, sequential DNA fingerprinting, full-sequencing and epityping, together with a fast time-to-result and low operating costs.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.